RxNorm 2530883
fosphenytoin sodium 50 MG/ML [Sesquient]
RxNorm Semantic Concepts
RxNorm semantic concepts for the RxCUI 2530883 unique identifier include: fosphenytoin sodium 50 MG/ML [Sesquient] (12616324).
RxNorm Atom ID: 12616324 - Semantic Branded Drug Component
fosphenytoin sodium 50 MG/ML [Sesquient]
- RXCUI:
- 2530883 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 12616324 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- NO - This drug IS NOT part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
- Concept Description:
- fosphenytoin sodium 50 MG/ML [Sesquient] - Description of concept identifier
- Term Type (TTY):
- SBDC - Term type in source with name and description
- Term Type Name:
- Semantic Branded Drug Component - Name of term type in source
- Term Type Description:
- Ingredient + Strength + Brand Name - Description of term type in source
- Code:
- 2530883 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- O
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- RXNORM - Concept source abbreviation
- Source Name:
- RxNorm Vocabulary - The official name for a source
- Source Version:
- 20AA_240603F - The source version
- Source Date:
- June 03, 2024 - RxNorm data last updated
- Source License Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information - Source Content Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information - Source Short Name:
- RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom 12616324 Attributes
Property | Value | Explanation |
---|---|---|
RXN ACTIVATED | 06/30/2021 | Date the RxNorm atom was reactivated |
RXN OBSOLETED | 01/30/2024 | Date the RxNorm atom became obsolete |
RXN OBSOLETED | 03/31/2021 | Date the RxNorm atom became obsolete |
* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Patient Education
Fosphenytoin Injection
Fosphenytoin injection is used to treat primary generalized tonic-clonic seizures (formerly known as a grand mal seizure; seizure that involves the entire body) and to treat and prevent seizures that may begin during or after surgery to the brain or nervous system. Fosphenytoin injection may also be used to control certain type of seizures in people who cannot take oral phenytoin. Fosphenytoin is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.